Skip to content
2000
Volume 7, Issue 3
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Antimitotic agents have been the most successful pharmacological agents for the treatment of cancer. The term "antimitotic agent" has traditionally been synonymous with tubulin-targeting compounds, but as a consequence of the large number of new compounds and mechanisms that have been identified recently, a much broader definition is currently needed. This review attempts to provide a broad overview of compounds and their cognate protein targets which result in a block in mitosis. Focus has been placed on agents that act directly on the mitotic machinery rather than on targets further upstream such as growth factor receptors.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945006776054933
2006-03-01
2025-11-02
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945006776054933
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test